EMA's CHMP recommends indication extension for Ionis' TRYNGOLZA in severe hypertriglyceridemia

Ionis Pharmaceuticals received a positive opinion from the EMA's CHMP recommending an indication extension for TRYNGOLZA for the treatment of adult patients with severe hypertriglyceridemia.

Detected & updated continuously · Source: Nebula

Story subjects

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula